Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...

Johnson & Johnson announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the ...

Tom Oxley, the Australian-born chief executive of brain chip company Synchron, has praised ­Donald Trump for having a ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

UChicago Pritzker Molecular Engineering study could lead to better brain-machine interfaces, biosensors, and pacemakers ...

Summary of Mount Sinai's New York BCI Symposium, by Synchron and Precision Neuroscience. Market Trends and forecast for brain ...

After years of battling depression, Eric, a middle-aged emergency worker, took a groundbreaking step—a brain implant.

AMD begins quietly, as cells in the retina, which converts light into signals for the brain, start to deteriorate. Over time, ...

Things are looking a little brighter now. In September, Neuralink received a "breakthrough device" designation from the Food ...

Max Verstappen has revealed that he and Red Bull “made some final adjustments” to help turn around a “terrible weekend” at the Mexican Grand Prix. Verstappen recovered from having his ...